You Searched For: 8-Oxa-3-aza-bicyclo[3.2.1]octane


7,248  results were found

SearchResultCount:"7248"

Sort Results

List View Easy View

Rate These Search Results

Supplier: Apollo Scientific
Description: 8-Oxa-3-aza-bicyclo[3.2.1]octane 98%

Catalog Number: (APOSPC430197-1G)
Supplier: Apollo Scientific
Description: 8-Boc-2-fluoro-8-aza-bicyclo[3.2.1]octan-3-one
UOM: 1 * 1 g


DURAN® protect+ safety coated bottle

Protect your HPAPIs with a cleanroom certified Fraunhofer IPA TESTED DEVICE®

Find out more

DWK Life Sciences

Learn more
Catalog Number: (APOSPC430315-1G)
Supplier: Apollo Scientific
Description: 2-(8-Aza-bicyclo[3.2.1]octan-3-yl)acetic acid 2,2,2-trifluoroacetate
UOM: 1 * 1 g


Catalog Number: (APOSPC430202-1G)
Supplier: Apollo Scientific
Description: 8-Boc-2-fluoro-8-azabicyclo[3.2.1]octan-3-ol
UOM: 1 * 1 g


Catalog Number: (APOSOR52275-250MG)
Supplier: Apollo Scientific
Description: Bicyclo[3.2.1]octan-3-one 95+%
UOM: 1 * 250 mg


Supplier: Apollo Scientific
Description: tert-Butyl-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate

Catalog Number: (APOSOR317208-1G)
Supplier: Apollo Scientific
Description: 5-Oxa-2-azaspiro[3.4]octane oxalate (2:1)
UOM: 1 * 1 g


Supplier: Apollo Scientific
Description: 3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride 97%

Supplier: Apollo Scientific
Description: 3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride 98%

Supplier: Thermo Scientific
Description: 8-Oxa-3-azabicyclo[3.2.1]octane hydrochloride 97%
Supplier: Apollo Scientific
Description: 8-Oxa-3-azabicyclo[3.2.1]octane hydrochloride 97%

Supplier: ENZO LIFE SCIENCES AG
Description: Highly potent, ATP-competitive, and specific mTOR kinase inhibitor. Antiproliferative.

New Product

Supplier: Cayman Chemical
Description: WYE-125132 is an ATP-competitive inhibitor of mTOR (IC<sub>50</sub> = 0,19 nM) that inhibits signaling through both mTORC1 and mTORC2. It is selective for mTOR over phosphatidylinositol 3-kinase isoforms. WYE-125132 is effective against mTORC1 and mTORC2 in diverse cancer models, both <i>in vitro</i> and <i>in vivo</i>. Oral administration of WYE-125132 alone blocks mTOR signaling and prevents tumor growth in breast, lung, renal, and glioma cancer xenografts in mice, while combination therapy with the VEGF-inhibitor bevacizumab causes complete regression of A498 renal carcinoma tumors. In addition to its applications in cancer, WYE-125132 has been used to delineate novel aspects of mTOR signaling.

Supplier: Apollo Scientific
Description: 3-Boc-6-oxo-3-aza-bicyclo[3.1.1]heptane

Supplier: Apollo Scientific
Description: 2,4,4,6-Tetramethyl-1-oxa-3-aza-2-cyclohexene 95%

Supplier: Apollo Scientific
Description: (1R*,2S*,4S*)-7-Aza-bicyclo[2.2.1]heptane-2,7-dicarboxylic acid 7-tert-butyl ester

Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on +353 1 88 22222.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us on +353 1 88 22222
This product is marked as restricted and can only be purchased by approved Shipping Accounts. If you need further assistance, email VWR Regulatory Department at eurega_services@eu.vwr.com
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organisation. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
Product(s) marked with this symbol are discontinued - sold till end of stock. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service on +353 1 8822222.
1 - 16 of 7,248
no targeter for Bottom